Evaluating the effect of N-acetyl cysteine on the Early Remodeling Biomarkers (MMPs & NT-Pro-BNP) in patients following acute myocardial infarction.

Trial Profile

Evaluating the effect of N-acetyl cysteine on the Early Remodeling Biomarkers (MMPs & NT-Pro-BNP) in patients following acute myocardial infarction.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Acetylcysteine (Primary)
  • Indications Myocardial infarction
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 18 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top